.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Baxter
Citi
US Department of Justice
McKesson
Teva
Novartis
Cerilliant
Argus Health
Julphar

Generated: June 28, 2017

DrugPatentWatch Database Preview

Indecainide hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for indecainide hydrochloride and what is the scope of indecainide hydrochloride freedom to operate?

Indecainide hydrochloride
is the generic ingredient in one branded drug marketed by Lilly and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Summary for Generic Name: indecainide hydrochloride

Tradenames:1
Patents:1
Applicants:1
NDAs:1
Bulk Api Vendors: see list3
Clinical Trials: see list2,244
Patent Applications: see list48
Drug Prices:see low prices
DailyMed Link:indecainide hydrochloride at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly
DECABID
indecainide hydrochloride
TABLET, EXTENDED RELEASE;ORAL019693-003Dec 29, 1989DISCNNoNo► Subscribe► Subscribe
Lilly
DECABID
indecainide hydrochloride
TABLET, EXTENDED RELEASE;ORAL019693-002Dec 29, 1989DISCNNoNo► Subscribe► Subscribe
Lilly
DECABID
indecainide hydrochloride
TABLET, EXTENDED RELEASE;ORAL019693-001Dec 29, 1989DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: indecainide hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Lilly
DECABID
indecainide hydrochloride
TABLET, EXTENDED RELEASE;ORAL019693-002Dec 29, 19894,382,093► Subscribe
Lilly
DECABID
indecainide hydrochloride
TABLET, EXTENDED RELEASE;ORAL019693-002Dec 29, 19894,452,745► Subscribe
Lilly
DECABID
indecainide hydrochloride
TABLET, EXTENDED RELEASE;ORAL019693-001Dec 29, 19894,382,093► Subscribe
Lilly
DECABID
indecainide hydrochloride
TABLET, EXTENDED RELEASE;ORAL019693-001Dec 29, 19894,452,745► Subscribe
Lilly
DECABID
indecainide hydrochloride
TABLET, EXTENDED RELEASE;ORAL019693-003Dec 29, 19894,382,093► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Cantor Fitzgerald
AstraZeneca
Boehringer Ingelheim
Fuji
Cerilliant
QuintilesIMS
McKinsey
McKesson
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot